A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke

Clinical trial NCT06712004 · RECRUITING

Trial details

NCT number: NCT06712004
Sponsor: Zhujiang Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke, Acute Ischemic Stroke Cerebral Infarction Brain Diseases

Start date: 2025-02-10
Primary completion: 2025-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.